Medico Remedies

{
  "main_header": {
    "sid": 1002925,
    "name": "Medico Remedies",
    "stock_name": "Medico Remedies",
    "full_name": "Medico Remedies Ltd",
    "name_url": "stocks-analysis/medico-remedies",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "49.06",
    "chg": -0.6,
    "chgp": "-1.21%",
    "dir": -1,
    "prev_price": "49.66",
    "mcapval": "410.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540937,
    "symbol": "MEDICO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE630Y01024",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "08:28 AM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": "19.06 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/medico-remedies-1002925-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Medico Remedies Ltd Upgraded to Hold by MarketsMOJO on Improved Fundamentals and Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-upgraded-to-hold-by-marketsmojo-on-improved-fundamentals-and-technicals-4125352",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicoRemediesL_mojoScore_4125352.png",
        "date": "2026-07-29 08:34:15",
        "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 28 July 2026. This change reflects a nuanced improvement across technical indicators, financial trends, valuation metrics, and overall company quality, signalling a cautious but more optimistic outlook for investors."
      },
      {
        "title": "Medico Remedies Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-sell-4107860",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicoRemediesL_mojoScore_4107860.png",
        "date": "2026-07-19 10:10:38",
        "description": "Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Medico Remedies Ltd Downgraded to Sell Amid Technical Weakness and Growth Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-downgraded-to-sell-amid-technical-weakness-and-growth-concerns-4093063",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicoRemediesL_mojoScore_4093063.png",
        "date": "2026-07-08 08:31:44",
        "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 7 July 2026. This shift reflects a combination of deteriorating technical indicators, subdued long-term growth prospects, and mixed financial performance despite recent quarterly improvements. The company’s Mojo Score now stands at 47.0, signalling caution for investors amid a challenging market backdrop."
      },
      {
        "title": "Medico Remedies Ltd Upgraded to Hold on Improved Technicals and Financial Metrics",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-upgraded-to-hold-on-improved-technicals-and-financial-metrics-4087107",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MedicoRemediesL_mojoScore_4087107.png",
        "date": "2026-07-03 08:21:20",
        "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 2 July 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive outlook for investors."
      },
      {
        "title": "Medico Remedies Ltd Downgraded to Sell Amid Technical Weakness and Growth Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-downgraded-to-sell-amid-technical-weakness-and-growth-concerns-4069858",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MedicoRemediesL_mojoScore_4069858.png",
        "date": "2026-06-24 08:33:49",
        "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 23 June 2026. This change reflects a deterioration in technical indicators alongside concerns over the company’s long-term growth prospects despite recent positive quarterly financial results."
      },
      {
        "title": "Medico Remedies Ltd Upgraded to Hold as Technicals Improve and Financials Strengthen",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-upgraded-to-hold-as-technicals-improve-and-financials-strengthen-4058421",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MedicoRemediesL_mojoScore_4058421.png",
        "date": "2026-06-17 08:34:50",
        "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 16 June 2026. This change reflects a nuanced improvement across technical indicators, financial performance, valuation metrics, and overall quality assessments, signalling a cautious but positive outlook for investors."
      },
      {
        "title": "Medico Remedies Ltd Downgraded to Sell Amid Technical Weakness and Growth Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-downgraded-to-sell-amid-technical-weakness-and-growth-concerns-4048474",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MedicoRemediesL_mojoScore_4048474.png",
        "date": "2026-06-12 08:19:14",
        "description": "Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 June 2026. This shift reflects a combination of deteriorating technical indicators, tempered long-term growth prospects, and valuation concerns despite recent positive quarterly financial results."
      },
      {
        "title": "Medico Remedies Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/medico-remedies-ltd-is-rated-hold-by-marketsmojo-4025951",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MedicoRemediesL_mojoScore_4025951.png",
        "date": "2026-06-01 10:10:51",
        "description": "Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Are Medico Remedies Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-medico-remedies-ltd-latest-results-good-or-bad-4007117",
        "imagepath": "",
        "date": "2026-05-22 19:28:43",
        "description": "Medico Remedies Ltd's latest financial results for the quarter ending March 2026 present a mixed operational narrative. The company reported a record net sales figure of ₹56.81 crores, reflecting a year-on-year growth of 37.55% compared to ₹41.30 crores in the same quarter last year. This indicates strong demand and sales momentum. Additionally, the net profit after tax surged to ₹5.86 crores, marking a year-on-year increase of 35.02%, which is a notable achievement.\n\nHowever, when examining the sequential performance, the results reveal some challenges. Revenue declined by 3.19% from the previous quarter's ₹58.68 crores, suggesting potential fluctuations in order execution or seasonal demand variations. Furthermore, the operating margin contracted to 12.59%, down from 16.15% in the same quarter last year, indicating volatility in profitability.\n\nThe company's return on equity remains robust at 17.35%, show..."
      }
    ],
    "total": 194,
    "sid": "1002925",
    "stock_news_url": "https://www.marketsmojo.com/news/medico-remedies-1002925"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>2:10</strong> stock split, ex-date: 16 Mar 23",
          "dt": "2023-03-16",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Medico Remedies Ltd has announced <strong>3:1</strong> bonus issue, ex-date: 16 Nov 21",
          "dt": "2021-11-16",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Medico Remedies Ltd Upgraded to Hold by MarketsMOJO on Improved Fundamentals and Technicals

2026-07-29 08:34:15

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 28 July 2026. This change reflects a nuanced improvement across technical indicators, financial trends, valuation metrics, and overall company quality, signalling a cautious but more optimistic outlook for investors.

Read full news article

Medico Remedies Ltd is Rated Sell

2026-07-19 10:10:38

Medico Remedies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Medico Remedies Ltd Downgraded to Sell Amid Technical Weakness and Growth Concerns

2026-07-08 08:31:44

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 7 July 2026. This shift reflects a combination of deteriorating technical indicators, subdued long-term growth prospects, and mixed financial performance despite recent quarterly improvements. The company’s Mojo Score now stands at 47.0, signalling caution for investors amid a challenging market backdrop.

Read full news article

Medico Remedies Ltd Upgraded to Hold on Improved Technicals and Financial Metrics

2026-07-03 08:21:20

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 2 July 2026. This change reflects a nuanced improvement across technical indicators, valuation metrics, financial trends, and overall quality assessments, signalling a cautious but positive outlook for investors.

Read full news article

Medico Remedies Ltd Downgraded to Sell Amid Technical Weakness and Growth Concerns

2026-06-24 08:33:49

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 23 June 2026. This change reflects a deterioration in technical indicators alongside concerns over the company’s long-term growth prospects despite recent positive quarterly financial results.

Read full news article

Medico Remedies Ltd Upgraded to Hold as Technicals Improve and Financials Strengthen

2026-06-17 08:34:50

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating upgraded from Sell to Hold as of 16 June 2026. This change reflects a nuanced improvement across technical indicators, financial performance, valuation metrics, and overall quality assessments, signalling a cautious but positive outlook for investors.

Read full news article

Medico Remedies Ltd Downgraded to Sell Amid Technical Weakness and Growth Concerns

2026-06-12 08:19:14

Medico Remedies Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 11 June 2026. This shift reflects a combination of deteriorating technical indicators, tempered long-term growth prospects, and valuation concerns despite recent positive quarterly financial results.

Read full news article

Medico Remedies Ltd is Rated Hold by MarketsMOJO

2026-06-01 10:10:51

Medico Remedies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Are Medico Remedies Ltd latest results good or bad?

2026-05-22 19:28:43

Medico Remedies Ltd's latest financial results for the quarter ending March 2026 present a mixed operational narrative. The company reported a record net sales figure of ₹56.81 crores, reflecting a year-on-year growth of 37.55% compared to ₹41.30 crores in the same quarter last year. This indicates strong demand and sales momentum. Additionally, the net profit after tax surged to ₹5.86 crores, marking a year-on-year increase of 35.02%, which is a notable achievement. However, when examining the sequential performance, the results reveal some challenges. Revenue declined by 3.19% from the previous quarter's ₹58.68 crores, suggesting potential fluctuations in order execution or seasonal demand variations. Furthermore, the operating margin contracted to 12.59%, down from 16.15% in the same quarter last year, indicating volatility in profitability. The company's return on equity remains robust at 17.35%, show...

Read full news article

View All News